Gregory J Dore (G J Dore, Greg John Dore)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 31

Top Topics

Systematic Review

Antiretroviral Therapy

Hepatitis C Virus

Chronic Myeloid Leukemia

Top Venues

Journal of viral hepatitis

Addiction (Abingdon, England)

Liver international : official journal of the International Association for the Study of the Liver

Drug and alcohol review

This page only lists publications with an associated author ORCID identifier.

Publications

Abdullah Farooq, Heather Valerio, Alice Wheeler, Marianne Martinello, Charles Henderson, David Silk, Louisa Degenhardt, Phillip Read, Gregory J Dore, Jason Grebely, Evan B Cunningham, null null
Needle and syringe sharing among people who have recently injected drugs in Australia: The ETHOS Engage Study. Drug and alcohol review (2024)
Hannah Ryan, Gregory J Dore, Jason Grebely, Marianne Byrne, Evan B Cunningham, Marianne Martinello, Andrew R Lloyd, Behzad Hajarizadeh
Hepatitis C treatment outcome among people in prison: The SToP-C study. Liver international : official journal of the International Association for the Study of the Liver (2024)
Abdullah Farooq, Heather Valerio, Alice Wheeler, Marianne Martinello, Charles Henderson, David Silk, Louisa Degenhardt, Phillip Read, Gregory J Dore, Jason Grebely, Evan B Cunningham, null null
Needle and syringe sharing among people who have recently injected drugs in Australia: The ETHOS Engage Study. Drug and alcohol review 43 (4) (2024)
Abdullah Farooq, Heather Valerio, Alice Wheeler, Marianne Martinello, Charles Henderson, David Silk, Louisa Degenhardt, Phillip Read, Gregory J Dore, Jason Grebely, Evan B Cunningham, null null
Needle and syringe sharing among people who have recently injected drugs in Australia: The ETHOS Engage Study. Drug and alcohol review 43 (4) (2024)
Mohammad Tahir Yousafzai, Maryam Alavi, Heather Valerio, Behzad Hajarizadeh, Jason Grebely, Gregory J Dore
Hepatitis C care cascade before and during the direct-acting antiviral eras in New South Wales, Australia: A population-based linkage study. Journal of viral hepatitis 30 (3) (2023)
Mohammad Tahir Yousafzai, Maryam Alavi, Heather Valerio, Behzad Hajarizadeh, Jason Grebely, Gregory J Dore
Hepatitis C care cascade before and during the direct-acting antiviral eras in New South Wales, Australia: A population-based linkage study. Journal of viral hepatitis 30 (3) (2023)
Yuen Kang Joseph Yeoh, Gregory J Dore, Ian Lockart, Thomas Berg, Ciara Flynn, Conner Blackmore, Miriam Tania Levy, Jacob George, Maryam Alavi, Behzad Hajarizadeh
Temporal change in aetiology and clinical characteristics of hepatocellular carcinoma in a large cohort of patients in New South Wales, Australia. Internal medicine journal (2023)
Mohammad Tahir Yousafzai, Maryam Alavi, Heather Valerio, Behzad Hajarizadeh, Jason Grebely, Gregory J Dore
Hepatitis C care cascade before and during the direct-acting antiviral eras in New South Wales, Australia: A population-based linkage study. Journal of viral hepatitis 30 (3) (2023)
Behzad Hajarizadeh, Joanne M Carson, Marianne Byrne, Jason Grebely, Evan B Cunningham, Janaki Amin, Peter Vickerman, Natasha K Martin, Carla Treloar, Marianne Martinello, Andrew R Lloyd, Gregory J Dore, null null
Incidence of hepatitis C virus infection in the prison setting: The SToP-C study. Journal of viral hepatitis (2023)
Jenny Iversen, Handan Wand, Hamish McManus, Gregory J Dore, Lisa Maher
Incidence of primary hepatitis C virus infection among people who inject drugs in Australia pre- and post- unrestricted availability of direct acting antiviral therapies. Addiction (Abingdon, England) (2022)
Ian Lockart, Malcolm G H Yeo, Behzad Hajarizadeh, Gregory J Dore, Thomas Berg
HCC incidence after hepatitis C cure among patients with advanced fibrosis or cirrhosis: A meta-analysis. Hepatology (Baltimore, Md.) 76 (1) (2022)
Jack Stone, Aaron Guanliang Lim, Gregory J Dore, Annick Borquez, Louise Geddes, Richard Gray, Jason Grebely, Bezhad Hajarizadeh, Jenny Iversen, Lisa Maher, Heather Valerio, Natasha K Martin, Matthew Hickman, Andrew R Lloyd, Peter Vickerman
Prison-based interventions are key to achieving HCV elimination among people who inject drugs in New South Wales, Australia: A modelling study. Liver international : official journal of the International Association for the Study of the Liver (2022)
Mohammad Tahir Yousafzai, Maryam Alavi, Heather Valerio, Behzad Hajarizadeh, Jason Grebely, Gregory J Dore
Hepatitis C care cascade before and during the direct-acting antiviral eras in New South Wales, Australia: A population-based linkage study. Journal of viral hepatitis (2022)
Jenny Iversen, Handan Wand, Hamish McManus, Gregory J Dore, Lisa Maher
Incidence of primary hepatitis C virus infection among people who inject drugs in Australia pre- and post-unrestricted availability of direct acting antiviral therapies. Addiction (Abingdon, England) (2022)
Mohammad Tahir Yousafzai, Maryam Alavi, Heather Valerio, Behzad Hajarizadeh, Jason Grebely, Gregory J Dore
Hepatitis C care cascade before and during the direct-acting antiviral eras in New South Wales, Australia: A population-based linkage study. Journal of viral hepatitis (2022)
María Patricia Hernández-Mitre, Steven Y C Tong, Justin T Denholm, Gregory J Dore, Asha C Bowen, Sharon R Lewin, Balasubramanian Venkatesh, Thomas E Hills, Zoe K McQuilten, David L Paterson, Susan C Morpeth, Jason Alexander Roberts
Nafamostat Mesylate for Treatment of COVID-19 in Hospitalised Patients: A Structured, Narrative Review. Clinical pharmacokinetics 61 (10) (2022)
Samira Hosseini-Hooshyar, Maryam Alavi, Marianne Martinello, Heather Valerio, Shane Tillakeratne, Gail V Matthews, Gregory J Dore
Evaluation of the hepatitis C cascade of care among people living with HIV in New South Wales, Australia: A data linkage study. Journal of viral hepatitis 29 (4) (2022)
Mohammad Tahir Yousafzai, Maryam Alavi, Heather Valerio, Behzad Hajarizadeh, Jason Grebely, Gregory J Dore
Hepatitis C care cascade before and during the direct-acting antiviral eras in New South Wales, Australia: A population-based linkage study. Journal of viral hepatitis (2022)
Aaron Guanliang Lim, Jack Stone, Behzad Hajarizadeh, Marianne Byrne, Georgina M Chambers, Natasha K Martin, Jason Grebely, Gregory J Dore, Andrew R Lloyd, Peter Vickerman
Evaluating the Prevention Benefit of HCV Treatment: Modeling the SToP-C Treatment as Prevention Study in Prisons. Hepatology (Baltimore, Md.) 74 (5) (2021)
Gregory J Dore, Sahar Bajis
Hepatitis C virus elimination: laying the foundation for achieving 2030 targets. Nature reviews. Gastroenterology & hepatology 18 (2) (2021)
Jasmine Yee, Joanne M Carson, Behzad Hajarizadeh, Joshua Hanson, James O'Beirne, David Iser, Phillip Read, Anne Balcomb, Joseph S Doyle, Jane Davies, Marianne Martinello, Philiipa Marks, Gregory J Dore, Gail V Matthews, null null
High Effectiveness of Broad Access Direct-Acting Antiviral Therapy for Hepatitis C in an Australian Real-World Cohort: The REACH-C Study. Hepatology communications (2021)
Mohammad Tahir Yousafzai, Sahar Bajis, Maryam Alavi, Jason Grebely, Gregory J Dore, Behzad Hajarizadeh
Global cascade of care for chronic hepatitis C virus infection: A systematic review and meta-analysis. Journal of viral hepatitis 28 (10) (2021)
Gregory J Dore, Heather Valerio, Jason Grebely
Creating an environment for equitable access to direct-acting antiviral therapy for people who inject drugs with hepatitis C. Liver international : official journal of the International Association for the Study of the Liver 40 (10) (2020)
David Stephen Prince, Joseph Louis Pipicella, Melissa Fraser, Frank Alvaro, Michael Maley, Hong Foo, Paul MacConachie Middleton, Scott Anthony Davison, Gregory J Dore, Geoff William McCaughan, Miriam Tania Levy
Screening Emergency Admissions at Risk of Chronic Hepatitis C (SEARCH) to diagnose or 're-diagnose' infections is effective in Australia. Journal of viral hepatitis 28 (1) (2020)
Lise Lafferty, Jake Rance, Gregory J Dore, Andrew R Lloyd, Carla Treloar
The role of social capital in facilitating hepatitis C treatment scale-up within a treatment-as-prevention trial in the male prison setting. Addiction (Abingdon, England) 116 (5) (2020)
Jason Grebely, Phillip Read, Evan B Cunningham, Martin Weltman, Gail V Matthews, Adrian Dunlop, Mark Montebello, Marianne Martinello, Rosie Gilliver, Philippa Marks, Tanya L Applegate, Gregory J Dore, null null
Elbasvir and grazoprevir for hepatitis C virus genotype 1 infection in people with recent injecting drug use (DARLO-C): An open-label, single-arm, phase 4, multicentre trial. Health science reports 3 (2) (2020)
Sichan He, Ian Lockart, Maryam Alavi, Thomas Berg, Behzad Hajarizadeh, Gregory J Dore
Systematic review with meta-analysis: effectiveness of direct-acting antiviral treatment for hepatitis C in patients with hepatocellular carcinoma. Alimentary pharmacology & therapeutics 51 (1) (2019)
Gregory J Dore
Commentary on Gountas et al. (2017): Time to focus on empirical evidence for HCV treatment as prevention. Addiction (Abingdon, England) 112 (7) (2019)
Maryam Alavi, Naveed Zafar Janjua, M Chong, Jason Grebely, Esther J Aspinall, H Innes, Heather Valerio, Behzad Hajarizadeh, P C Hayes, Mel Krajden, Janaki Amin, Matthew G Law, Jacob George, D J Goldberg, S J Hutchinson, Gregory J Dore
Trends in hepatocellular carcinoma incidence and survival among people with hepatitis C: An international study. Journal of viral hepatitis 25 (5) (2018)
Jason Grebely, Sarah Larney, Amy Peacock, Samantha Colledge-Frisby, Janni K Y Leung, Matthew Hickman, Peter Vickerman, Sarah Blach, Evan B Cunningham, Konstantin Dumchev, Michael T Nurmohamed, Jack Stone, Adam Trickey, Homie Razavi, Richard P Mattick, Michael Farrell, Gregory J Dore, Louisa Degenhardt
Global, regional, and country-level estimates of hepatitis C infection among people who have recently injected drugs. Addiction (Abingdon, England) 114 (1) (2018)
Jisoo A Kwon, Gregory J Dore, Jason Grebely, Behzad Hajarizadeh, Rebecca J Guy, Evan B Cunningham, Cherie Power, Chris Estes, Homie Razavi, Richard T Gray, null null
Australia on track to achieve WHO HCV elimination targets following rapid initial DAA treatment uptake: A modelling study. Journal of viral hepatitis 26 (1) (2018)